REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/13/2026
Back to search
Official data from USPTO
MURELTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/14/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 10
Filing date
12/18/2019
Registration date
04/13/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2021
Last transaction
04/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
61118 Bad Vilbel, DE
Examiner
POLLACK, ALISON FRIEDBERG
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
STADA Arzneimittel AG
Representatives
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabeticoncologicalmacular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
Class 10
Applicators in the nature of droppers and syringes for administering medications into the human eyesold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
Publications
History of USPTO decisions and trademark events.
42 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/14/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/26/2021
FIMP
FINAL DISPOSITION PROCESSED
07/26/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/13/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/26/2021
PUBO
PUBLISHED FOR OPPOSITION
01/26/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/06/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/21/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/21/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/21/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2020
ALIE
ASSIGNED TO LIE
12/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2020
RFNT
REFUSAL PROCESSED BY IB
08/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/27/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/27/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/27/2020
CNRT
NON-FINAL ACTION MAILED
07/06/2020
CNRT
NON-FINAL ACTION WRITTEN
07/02/2020
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
07/01/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/22/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/24/2020
RFRR
REFUSAL PROCESSED BY MPU
03/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/04/2020
CNRT
NON-FINAL ACTION WRITTEN
03/03/2020
DOCK
ASSIGNED TO EXAMINER
03/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/13/2020
Continuous trademark protection
Get notified about every new filing that threatens MURELTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.